The information on this Website is not reliable and not intended to provide tax, legal, or investment advice. Nothing contained on the Website shall be considered a recommendation, solicitation, or offer to buy or sell a security to any person in any jurisdiction.
CEO.CA members discuss high-risk penny stocks which can lose their entire value. Only risk what you can afford to lose.
Members of
@nasdaq/insys-therapeutics-announces-first-patient-enrolled-in-phase-ii-trial-for-the-treatment-of-cocaine-dependence-using-pharmaceutical-cannabidiol